Clifton Park, NY, United States of America

Dennis J Hlasta

This inventor holds 24 USPTO granted patents, primarily in Proteolytic Enzyme Inhibitors. Top assignees: Sterling Winthrop Inc., Sanofi, Sanofi Sa. Active years: 1991-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis J Hlasta. Retrieved from https://idiyas.com/inventor/dennis-j-hlasta-bdjfxzf9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 10

Forward Citations = 419(Granted Patents)


Location History:

  • Clifton Park Township, Saratoga County, NY (US) (1992)
  • Lower Selford, NY (US) (1997)
  • Lower Salford Township, Montgomery County, PA (US) (1994 - 1998)
  • Clifton Park, NY (US) (1991 - 1999)

Company Filing History:


Years Active: 1991-1999

Loading Chart...
Areas of Expertise:
Proteolytic Enzyme Inhibitors
Saccharin Derivatives
Heterocyclic Carboxylates
Enzyme Inhibition
Dihydro-1H-Indoles
Thiadiazolidin-3-One
Phosphates
Phosphonates
Aryl Carboxylates
Pyrazol
Carboxylates
24 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Inventor Dennis J Hlasta

Introduction

Dennis J Hlasta, a prolific inventor based in Clifton Park, NY, has made significant contributions to the field of chemistry and pharmacology. With an impressive portfolio of 24 patents, his innovations have paved the way for advancements in therapeutic treatments.

Latest Patents

Among his notable recent inventions are two patents focused on 2-Saccharinylmethyl heterocyclic carboxylates. These compounds are designed for use as proteolytic enzyme inhibitors, particularly in the treatment of degenerative diseases. The development involves a method of preparing these derivatives by reacting a 4-R.sup.4 -R.sup.5 -2-halomethylsaccharin with a heterocyclic carboxylic acid in the presence of an acid-acceptor or the alkali metal salt of said acid. His work on saccharin derivative proteolytic enzyme inhibitors is recognized for its potential therapeutic benefits.

Career Highlights

Throughout his career, Dennis J Hlasta has been associated with several notable organizations, including Sterling Winthrop Inc. and Sanofi. His expertise and innovative spirit have significantly contributed to the advancements within these companies, making him a respected figure in his field.

Collaborations

In his journey, Dennis has collaborated with esteemed professionals such as Ranjit C Desai and Richard P Dunlap. These partnerships have facilitated an exchange of ideas and fostered innovation, resulting in groundbreaking advancements in their projects.

Conclusion

Dennis J Hlasta's work exemplifies the spirit of innovation, showcasing how scientific research and collaboration can lead to impactful inventions. His contributions to the field of pharmacology not only demonstrate his talent as an inventor but also highlight the importance of continuous research in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…